Latest Breaking News On - Tsukuba research laboratories - Page 1 : comparemela.com

World's first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment

World's first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Japan
Khartoum
Al-khartum
Sudan
Netherlands
Mexico
Sudanese
Japanese
Kappei-tsukahara
Ahmed-fahal
Borna-nyaoke
Head-of-the-mycetoma-disease-programme

Eisai Co., Ltd. - LEQEMBI Intravenous Infusion Approved for the Treatment of Alzheimer's disease in Japan

TOKYO - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti-soluble aggregated amyloid-beta monoclonal antibody LEQEMBI Intravenous Infusion has been approved in Japan as a.

Massachusetts
United-states
Israel
Japan
Canada
Cambridge
Cambridgeshire
United-kingdom
Australia
China
Tsukuba
Ibaraki

LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan - Biogen (NASDAQ:BIIB)

TOKYO and CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO:

Canada
Israel
South-korea
China
Cambridge
Cambridgeshire
United-kingdom
Australia
Massachusetts
United-states
Switzerland
Japan

Biogen Inc.: LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan

Biogen Inc.: LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan
Cambridge
Cambridgeshire
United-kingdom
Israel
Tsukuba
Ibaraki
Tokyo
Massachusetts
United-states
Canada
China

LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan | 25.09.23

LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan | 25.09.23
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

China
Tsukuba
Ibaraki
Japan
Tokyo
Cambridge
Cambridgeshire
United-kingdom
Switzerland
South-korea
Israel
Australia